Myhre B A, Johnson D, Marcus C S, Demaniew S, Carmen R, Nelson E
Department of Pathology, Los Angeles County Harbor-UCLA Medical Center, Torrance.
Vox Sang. 1987;53(4):199-202. doi: 10.1111/j.1423-0410.1987.tb05066.x.
Whole blood and red cells were stored using citrate-phosphate-dextrose (CPD) and citrate-phosphate-dextrose-adenine (CPDA-1) anticoagulants in polyvinylchloride bags made flexible with di-(2-ethylhexyl)phthalate (DEHP) or tri-(2-ethylhexyl)trimellitate (TOTM) plasticizers. After storage the posttransfusion viability of these cells was tested in autologous donors. Cells stored in TOTM-plasticized film had a survival rate less than 75% when stored for 35 days, while other systems had a survival greater than this. When compared with the red cells stored in CPD-DEHP-plasticized film, the viability of whole blood and red cells stored in CPDA-TOTM showed a statistically significant decrease (p = less than 0.01). Therefore, red cell storage in TOTM-plasticized PVC with current anticoagulant should be limited to 21 days.
全血和红细胞使用柠檬酸盐 - 磷酸盐 - 葡萄糖(CPD)和柠檬酸盐 - 磷酸盐 - 葡萄糖 - 腺嘌呤(CPDA - 1)抗凝剂,保存在用邻苯二甲酸二(2 - 乙基己基)酯(DEHP)或偏苯三酸三(2 - 乙基己基)酯(TOTM)增塑剂制成的柔性聚氯乙烯袋中。储存后,在自体供体中测试这些细胞的输血后活力。储存在TOTM增塑薄膜中的细胞在储存35天时存活率低于75%,而其他系统的存活率高于此。与储存在CPD - DEHP增塑薄膜中的红细胞相比,储存在CPDA - TOTM中的全血和红细胞活力有统计学显著下降(p = 小于0.01)。因此,使用当前抗凝剂在TOTM增塑的PVC中储存红细胞应限制在21天以内。